Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor

NCT05834777 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Intradialytic Hypotension

Interventions

DRUG: Icatibant
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]